Pfizer Inc
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.52+0.57 (+1.90%)
Close on Oct 30, 2026Market cap $173.95BP/E 40.2Yield 5.64%
Pfizer Oxbryta (voxelotor by Year
Oxbryta (voxelotor — voluntarily withdrawn Sept 2024) [legacy through FY24] ($M) ($M)
Pfizer Oxbryta (voxelotor: $201M in FY2024, down 38.7% from a year earlier. No newer figure appears in the documents we track.
Latest, FY2024
201
Period ended Dec 31, 2024
Change on a year earlier
-38.7%
328 in FY2023
History
5 years
Since FY2020
Sources
3
Documents cited below
Where the FY2024 figure comes from
Source: Form 10-K (filed 2025-02-27) ↗
Reported in Form 10-K Segment Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Oxbryta (voxelotor — voluntarily withdrawn Sept 2024) [legacy through FY24] ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2024 | Dec 31, 2024 | 201 | -38.7% | Form 10-K (filed 2025-02-27) ↗ |
| FY2023 | Dec 31, 2023 | 328 | +349.3% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 73 | – | Form 10-K (filed 2025-02-27) ↗ |
| FY2021 | Dec 31, 2021 | 0 | – | Form 10-K (filed 2024-02-22) ↗ |
| FY2020 | Dec 31, 2020 | 0 | – | Form 10-K (filed 2023-02-23) ↗ |
Cite this data
StockData. (2026). Pfizer Oxbryta (voxelotor ($M), annual FY2020–FY2024 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/oxbryta-leg
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.